Date of Document: December 5, 2023
CURRICULUM VITAE

Edward M. Barnett MD, PhD
Professor
Department of Ophthalmology and Visual Sciences

OFFICE ADDRESS:
Eye Institute
925 N 87 St
Milwaukee, WI 53226

EDUCATION:
08/1983 - 05/1988 B.S. with Honors, Psychology University of Wisconsin, Madison, WI
08/1988 - 05/1995 M.D. University of Iowa College of Medicine, Iowa City, IA
08/1988 - 05/1995 Ph.D., Neuroscience University of Iowa, Iowa City, IA

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/1995 - 06/1996 Transitional Year Internship, St. Lukes Medical Center, Milwaukee, WI
07/1996 - 06/1999 Resident, Department of Ophthalmology & Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, IA
07/1999 - 06/2000 Fellowship, Department of Ophthalmology & Visual Sciences, Glaucoma, Washington University in St. Louis/Barnes Jewish Hospital, St. Louis, MO

FACULTY APPOINTMENTS:
07/2000 - 07/2001 Assistant Professor, The Eye and Ear Institute, University of Pittsburgh, Pittsburgh, PA
08/2001 - 05/2006 Assistant Professor, Department of Ophthalmology & Visual Sciences, Washington University in St. Louis, St. Louis, MO
06/2006 - 05/2012 Associate Professor, Department of Ophthalmology & Visual Sciences, Washington University in St. Louis, St. Louis, MO
08/2010 - 07/2011 Adjunct Assistant Professor, College of Optometry, University of Missouri-St. Louis, St. Louis, MO
06/2012 - 06/2013 Professor, Department of Ophthalmology & Visual Sciences, Washington University in St. Louis, St. Louis, MO
06/2015 - Present Professor, Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
08/2001 - 06/2008 Coordinator, Resident Lecture Series - Glaucoma, Department of Ophthalmology & Visual Sciences, Washington University in St. Louis, St. Louis, MO
08/2001 - 06/2013 Co-director, Glaucoma Fellowship, Department of Ophthalmology & Visual Sciences, Washington University in St. Louis/Barnes Jewish Hospital, St. Louis, MO

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
07/2000 - 07/2001 Director, Glaucoma Service, The Eye and Ear Institute, University of Pittsburgh, Pittsburgh, PA
06/2006 - 06/2013 Clinical Director, Department of Ophthalmology & Visual Sciences, Washington University in St. Louis, St. Louis, MO
05/01/2018 - Present Director, Department of Ophthalmology and Visual Science, Glaucoma Service

HOSPITAL STAFF PRIVILEGES:
06/25/13 - 05/31/15 Massachusetts Eye and Ear Infirmary, 243 Charles St. Boston, MA 02114
07/17/13 - 05/31/15 Tufts Medical Center, 800 Washington St., Box 836 Boston, MA 02111-1552
11/21/13 - 05/31/15 Massachusetts General Hospital, 55 Fruit St. Boston, MA 02114
06/01/15 - Present Children's Hospital of Wisconsin, 8915 W. Connell Ct. Milwaukee, WI 53226
06/11/15 - Present Froedtert Hospital, 9200 W. Wisconsin Ave. Milwaukee, WI 53226-3596
07/01/1999 - 06/30/2000 Barnes Jewish Hospital, 1 Barnes Jewish Plaza St. Louis, MO 63110
07/12/1999 - 06/30/2000 John Cochran Veterans Administration Medical Center, 915 North Grand Ave. St. Louis, MO 63106
07/01/2000 - 07/31/2001 University of Pittsburgh Medical Center Presbyterian, 200 Lothrop St. Pittsburgh, PA 05213
09/26/2000 - 07/31/2001 University of Pittsburgh Medical Center St. Margaret, 815 Freeport Rd Pittsburgh, PA 15215
09/28/2000 - 07/31/2001 Stars and Stripes Healthcare Network, University Drive, Pittsburgh, PA 15402
08/10/2001 - 06/30/2013 Barnes Jewish Hospital, 1 Barnes Jewish Plaza, St. Louis, MO 63110
11/16/2001 - 09/04/2004 John Cochran Veterans Administration Medical Center, 915 N. Grand Ave. St. Louis, MO 63106
12/29/2010 - 02/27/2012 Barnes Jewish West County Hospital, 12634 Olive Blvd St. Louis, MO 63141
07/26/2015 - Present Staff Physician, Surgical Services - Ophthalmology, Clement J Zablocki VA Medical Center, 5000 West National Ave., Milwaukee, WI 53295

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Ophthalmology
05/2001
12/2031
American Board of Ophthalmology (MOC)
01/2012
12/2021
   
Certificates
Issued By Issue DateExpiration
Ex-Press Mini Glaucoma Shunt
Ciba Vision
05/2002
None
Endoscopic Cyclophotocoagulation
Endo Optiks
03/2007
None
Trabectome Level Two
Neomedix
2007
None
Trabectome Level One
Neomedix
2007
None
Trabectome Trainer
Neomedix
2008
None
iStent
Glaukos
2014
None
Physician Builder
EPIC
01/16/2016
None
BLS for Healthcare Providers
American Heart Association
03/2016
03/31/2024
    

Licensure
Number Issue DateExpiration
State of Missouri
MD118287
04/1999
01/2014
Commonwealth of Pennsylvania
MD-070738-L
04/2000
12/2002
Commonwealth of Massachusetts
254422
03/2013
06/2015
State of Wisconsin
63463-20
01/2015
10/2015
    

AWARDS AND HONORS:
1983 - 1988 College of Letters & Sciences Honors Program
1984 - Present Phi Eta Sigma Freshman Honor Society
1985 - Present Sophomore Honors, Honors Program
1986 - Present Golden Key National Honor Society
1986 - Present Honor Society of Phi Kappa Phi
1986 - Present Psi Chi national Honor Society in Psychology
1986 - Present Knapp-Brittingham Summer Honors Undergraduate Research Grant
1987 - Present Florence Waste Pulver Scholarship
1987 - Present Phi Beta Kappa
1991 - Present Alpha Omega Alpha Honor Medical Society
1993 - Present I. H. Borts Medical Student Research Award
1993 - Present American Federation for Clinical Research Medical Student Award
1994 - Present Edward Heath Medical Student Research Award
2006 - 2013 America's Top Ophthalmologists - Consumer's Research Council of America
2011 - 2014 Best Doctors in America
01/01/2016 - 12/31/2016 America's Top Ophthalmologists, SLD INdustries, Inc.
2018 - 2019 Clinical Faculty of the Year Award, Medical College of Wisconsin Department of Ophthalmology and Visual Science

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2001 - Present American Academy of Ophthalmology
2002 - Present American Glaucoma Society
2007 - 2013 Association for Research in Vision and Ophthalmology
2015 - Present Wisconsin Academy of Ophthalmology
2016 - Present Milwaukee Ophthalmological Society

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
2005 - 2011 Current Eye Research
Journal Review
2002 - Present 3, 2006-10, 2015 Ophthalmology
2003 - 8 American Journal of Ophthalmology
2003 - Present Archives of Ophthalmology
2004 - 2009 British Journal of Ophthalmology
2005 - 2008 9, 2012 Investigative Ophthalmology and Visual Sciences
2008 - Present Survey of Ophthalmology
2009 - Present Vision Research

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2009 RC2 GO Grant Review Committee, NIH, NIA Special Emphasis Panel
2015 - 2017 Patient Care Committee, Document Review Subcommittee, American Glaucoma Society
01/2018 - Present Glaucoma Subspecialty Day Planning Group, American Academy of Ophthalmology
2018 - 2020 Website Subcommittee, American Glaucoma Society

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Membrane Permeant Peptides for Imaging Cell Function
Source:
NIH R01 EY019587
Role:
Collaborator/Co-Investigator
Dates:
09/30/2013 - 09/29/2017
Direct Funds:
$1,600,000
  
Prior
Peer Review
Title:
The CNS Pathogenesis of a Murine Coronavirus
Source:
NIMH MH10384
Role:
Pre-Doctoral Fellow
Dates:
10/01/1992 - 05/31/1995
Direct Funds:
$60,288
  
Title:
Novartis Ophthalmics Research Fellowship in Glaucoma
Source:
American Glaucoma Society
Role:
Principal Investigator
Dates:
06/01/2002 - 05/31/2003
Direct Funds:
$32,000
  
Title:
In Vivo Imaging of Retinal Apoptosis Using Activatable Permeation Peptides
Source:
NIH R21 EY017636
Role:
Principal Investigator
Dates:
08/01/2006 - 07/31/2008
Direct Funds:
$275,000
  
Title:
American Glaucoma Society Mid-Career Physician Scientist Award
Source:
American Glaucoma Society
Role:
Principal Investigator
Dates:
07/01/2009 - 06/30/2010
Direct Funds:
$40,000
  
Title:
Membrane Permeant Peptides for Imaging Cell Function
Source:
NIH R01 EY019587
Role:
Co-Investigator
Dates:
2009 - 2013
  
Title:
The Ocular Hypertension Treatment Study
Source:
NIH U10 EY10438
Role:
Principal Site Investigator Washington University in St. Louis 07/01/2002-06/30/2008
  
Non-Peer Review
Title:
Medical Scientist Training Program
Source:
NIH through University of Iowa T32 GM07337
Role:
Trainee
Dates:
07/01/1988 - 09/30/1992
  
Title:
Xalatan vs. Alphagan
Source:
Pharmacia & Upjohn
Role:
Sub-Investigator
Dates:
07/01/1999 - 06/30/2000
  
Title:
Horncrest Physician Scientist Award
Source:
Horncrest Foundation, Inc.
Role:
Principal Investigator
Dates:
08/01/2001 - 07/31/2003
Direct Funds:
$160,000
  
Title:
Oral Tazarotene for Psoriasis
Source:
Allergan
Role:
Sub-Investigator
Dates:
2001 - 2003
  
Title:
Research to Prevent Blindness, Career Development Award
Source:
Research to Prevent Blindness
Role:
Principal Investigator
Dates:
01/01/2002 - 12/31/2005
Direct Funds:
$200,000
  
Title:
Pharmacia Glaucoma Fellows Research Grant
Source:
Pharmacia
Role:
Principal Investigator
Dates:
05/01/2002 - 04/30/2004
Direct Funds:
$40,000
  
Title:
Biomarker Study in Ocular Disease Utilizing Precision Profile Gene Expression Analysis of Whole Blood Sample RNA
Source:
Alcon Research, Ltd.
Role:
Principal Investigator
Dates:
05/13/2005 - 05/12/2007
Direct Funds:
$3,662
  
Title:
Grace Nelson Lacy Glaucoma Research Fund Award
Source:
Washington University in St. Louis
Role:
Principal Investigator
Dates:
07/01/2011 - 06/30/2013
Direct Funds:
$40,000
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Meeting Moderator: Satellite CME Broadcast- Progress in Treatment Modalities for Glaucoma, 3rd International Glaucoma Symposium, Pittsburgh, PA, 03/23/2001
The Ocular Hypertension Treatment Study: Translating Evidence into Practice, Nashville, TN, 10/29/2002
The Ocular Hypertension Treatment Study: Translating Evidence into Practice, Tulsa, OK, 11/13/2002
Current Topics in Glaucoma Management., St. Louis Optometric Society, St. Louis, MO, 09/09/2003
Current Topics in the Management of Glaucoma, Northwestern Ophthalmology Socoety, Chicago, IL, 06/01/2004
Glaucoma Perimetry and Imaging Update, Des Moines Ophthalmology Society, Des Moines, IA, 10/14/2004
Impact of Central Corneal Measures on Intraocular Pressure, Northwest Ophthalmology Society, Chicago, IL, 03/05/2005
Visiting Professor: Gonioscopy, University of Missouri-Kansas City, Kansas City, MO, 03/31/2006
Clinical Considerations and Molecular Imaging in Glaucoma, San Antonio Ophthalmologic Society, San Antonio, TX, 11/17/2011
Glaucoma: What is it? What should I know?, Glaucoma Awareness Month Presentation, Massachusetts General Hospital. Boston, MA, 01/29/2014
Glaucoma Imaging: Current Pitfalls and Future Potential, Grand Rounds- University of Wisconsin, Madison, WI, 05/16/2014
Glaucoma Imaging: Current Pitfalls, Future Potential, Milwaukee Ophthalmologic Society, Milwaukee, WI, 10/20/2015
Assessing Progression by Perimetry and OCT in Glaucoma, Medical College of Wisconsin Eye Institute 40th Anniversary Scientific Symposium, Milwaukee, WI, 10/01/2016 - Present
Update on Glaucoma Surgery - Expanding Options, Ascension/Affinity Medical Group Continuing Optometric Education, Neenah, WI, 10/26/2017 - Present
Barnett, Edward, Glaucoma Filtering Implants, Medical College of Wisconsin Department of Ophthalmnology Grand Rounds, Milwaukee, WI, 08/04/2021
Trends in Glaucoma, Brown University Ophthalmology Grand Rounds, Providence, RI
 
Regional
Bleb Complications and Blebitis, 24th Annual Midwest Glaucoma Society Meeting & Washington University in St. Louis Department of Ophthalmology & Visual Sciences Fall Update, St. Louis, MO, 10/06/2001
HRT Imaging in Glaucoma, Washington University in St. Louis Department of Ophthalmology & Visual Sciences Fall Update, St. Louis, MO, 08/04/2002
Imaging Technologies in Glaucoma: HRT, GDx, and OCT, Missouri Society of Eye Physicians & Surgeons Annual Meeting, Lake of the Ozarks, MO, 05/31/2003
Critical Analysis of Clinical Drug Studies and Product Claims, Michigan Ophthalmological Society, Detroit, MI, 09/17/2003
The Ocular Hypertension Treatment Study: Translating Evidence into Practice, Nebraska Optometric Association, Omaha, NE, 10/28/2003
Current Topics in the Management of Glaucoma, Nebraska Optometric Association, Omaha, NE, 05/07/2004
Glaucoma Perimetry and Imaging Update, Washington University in St. Louis Department of Ophthalmology and Visual Sciences Fall Update, St. Louis, MO, 09/11/2004
Detecting Glaucoma Progression: Perimetry, Imaging, and Beyond, Washington University Department of Ophthalmology & Visual Sciences Fall Update, St. Lois, MO, 09/16/2006
Assessing Retinal Ganglion Cells: Beyond Perimetry and Imaging, Iowa Eye Association Annual Meeting, Iowa City, IA, 06/14/2007
Endocyclophotocoagulation- Update on Minimally Invasive Glaucoma Surgery, New England Ophthalmological Society- 749th Meeting, Boston, MA, 04/11/2014
Glaucoma Management: From Meds to MIGS, Massachusetts Society of Eye Physicians and Surgeons, Waltham, MA, 09/30/2014
Challenges in Glaucoma Imaging with OCT, Eye Institute Annual Symposium, Wauwatosa, WI, 09/19/2015
Glaucoma Imaging with OCT: Challenges and Artifacts, Wisconsin Academy of Ophthalmology 2016 Symposium Clinical Program, Green Bay, WI, 02/27/2016
Perimetry in the Diagnosis and Management of Glaucoma, Wisconsin Academy of Ophthalmology 2016 Symposium Technician Program, Green Bay, WI, 02/27/2016
Minimally Invasive Glaucoma Surgery, Multiphasic Phaco Course, Madison, WI, 08/18/2017 - Present
Midwest Regional Phaco Course Wetlab Instructor, Multiphasic Phaco Course, Madison, WI, 08/19/2017 - Present
Molecular Imaging of Retinal Ganglion Cells for Apoptosis, 41st Annual Midwest Glaucoma Symposium, Milwaukee, WI, 09/28/2018 - Present
Minimally Invasive Glaucoma Surgery, Multiphasic Phaco Course, Madison, WI, 08/16/2019 - Present
Barnett, Edward, Glaucoma Filtering Implants, Wisconsin Academy of Ophthalmology, Milwaukee, WI, 03/18/2022
Barnett, Edward, Cataract Surgery Considerations for MIGS, Resident Phaco Course 2022, University of Wisconsin-Madison, 08/18/2022
The Ocular Hypertension Treatment Study, New Mexico State Ophthalmologic Society Annual Meeting, Albuquerque, NM
 
National
The Prostaglandin Analogs: Pharmacology & Efficacy-Glaucoma Update, 2003 Royal Hawaiin Eye Meeting, Maui, HI, 01/19/2003
Prostaglandins: Development and Comparison, 2003 Royal Hawaiin Eye Meeting, Maui, HI, 01/22/2003
Ocular Hypertension Treatment Study: Implications for Assessment and Management, JCAHPO 31st Annual Meeting, Anaheim, CA, 11/16/2003
Medical Management of Glaucoma, Storm Eye Institute/American Society for Cataract & Refractive Surgery 2003 Clinical Update, Kiawah Island, SC, 2003
Moderator: Experimental Optic Nerve Session, Association for Research in Vision and Ophthalmology 2004 Annual Meeting, Fort Lauderdale, FL, 04/23/2004
Should I Use Prostaglandins after Routine Uncomplicated Cataract Surgery?, Glaucoma Subspecialty Day- American Academy of Ophthalmology Annual Meeting, New Orleans, LA, 10/23/2004
Making the Transition to Running Your Own Clinic, CPE Glaucoma Fellows Program, Fort Worth, TX, 11/13/2004
Novel Medical Therapeutic Approaches for Glaucoma Patients: New Considerations in the Management of Ocular Hypertension and Glaucoma, 2005 Royal Hawaiin Eye Meeting, Hawaii, 01/16/2005
OHTS Update, 2005 Royal Hawaiian Eye Meeting, Hawaii, 01/19/2005
Making the Transition to Running Your Own Clinic, CPE Glaucoma Fellows Program, Fort Worth, TX, 11/04/2005
Glaucoma Drainage Implants, Washington University Department of Ophthalmology & Visual Sciences Ophthalmic Update 2006 for Nurses & Technicians, St. Louis, MO, 01/28/2006
Secondary Glaucomas, Washington University Department of Ophthalmology & Visual Sciences Ophthalmic Update 2007 for Nurses & Technicians, St. Louis, MO, 01/27/2007
Instructor: Angle/Schlemm Canal Surgery for Adult Open-Angle Glaucoma: Ab Interno Approach, American Academy of Ophthalmology 2008 Annual Meeting, Atlanta, 11/09/2008
Glaucoma Imaging, Washington University Department of Ophthalmology & Visual Sciences Ophthalmic Update 2009 for Nurses & Technicians, St. Louis, MO, 03/29/2010
Imaging Retinal Ganglion Cell Apoptosis Using Cell-penetrating Activatable Peptide Probes, Nanodiagnostics in Ophthalmology: A New Frontier Association for Research in Vision and Ophthalmology 2010 Meeting, Fort Lauderdale, FL, 05/04/2010
Instructor: Angle/Schlemm Canal Surgery for Adult Open-Angle Glaucoma: Ab Interno Approach, American Academy of Ophthalmology 2010 Annual Meeting, Chicago, IL, 10/17/2010
Case Studies in the Clinical Use of Glaucoma Imaging Devices, Washington University's Ophthalmic Personnel Update VII, St. Louis, MO, 02/26/2011
Trabecular Meshwork Ablation, Innovations in Glaucoma Surgery, St. Louis, MO, 04/14/2012
Instructor: Angle/Schlemm Canal Surgery for Adult Open-Angle Glaucoma: Ab Interno Approach, American Academy of Ophthalmology 2012 Annual Meeting, Chicago, IL, 11/13/2012
Imaging and Diagnostics: In Vivo Molecular Imaging of the Retina, American Ophthalmological Society 2012 Knapp Symposium - Nanotechnology in Ophthalmology, Charleston, SC, 2012
High Resolution Imaging of Retinal Ganglion Cell Apoptosis In Vivo using an Activatable Cell-Penetrating Peptide Probe, Basic/Clinical Science Lecture ARVO 2013 Meeting, Seattle, WA, 05/05/2013
Endoscopic Diode Cyclophotocoagulation, Innovations in Glaucoma Surgery, St. Louis, MO, 08/24/2013
Interpreting OCT Imaging in Glaucoma: Challenges and Artifact, American Academy of Ophthalmology 2015 Annual Meeting - Breakfast with the Experts sponsored by American Glaucoma Society, Las Vegas, NV, 11/15/2015
Shunt Assisted Trabeculectomy and Antifibrotics, 3rd Annual Innovations in Glaucoma Surgery, St. Louis, MO, 04/09/2016
Moderator: Open-Angle Glaucoma with Low Pressures, American Academy of Ophthalmology Glaucoma Subspecialty Day, San Francisco, CA, 08/08/2019
Moderator: Diagnostics/Visual Fields, American Academy of Ophthalmology Glaucoma Subspecialty Day, online, 11/13/2020
Approach to the Normal Pressure Glaucoma Patient, Ophthalmology Update: From Front to Back, Fajardo, Puerto Rico
The Ex-Press Glaucoma Mini Shunt, Ophthalmology Update: From Front to Back, Fajardo, Puerto Rico
Efficacy and Tolerability of Topical Prostaglandins, Latin America Expert Meeting, San Juan, Puerto Rico
 
International
Neuroprotection/Blood Flow: What We Know Today, Xalatan First-Line Symposium, Stockholm, Sweden, 06/29/2002
Prostaglandins: Development and Comparison; Neuroprotection in Glaucoma: Here Today? Here Tomorrow?, The 4th Japan Glaucoma Council, Tokyo, Japan, 12/07/2002
Clinical Update on Low Tension Glaucoma Treatment Overseas, Xalatan Symposium, Tokyo, Japan, 08/23/2003
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Qui X, Johnson JR, Piwnica-Worms D, Barnett EM. In vivo imaging of retinal ganglion cell apoptosis using caspase-activatable cell-penetrating probes in the rat: Optimizing signal-to-noise and assessing potential toxicity. Association
Barnett EM, Cassell M, Perlman S. Tracing olfactory pathways in the mouse with a coronavirus. Society for Neuroscience Abstracts 1991; 17:1511.
Barnett EM, Perlman, S. Mouse hepatitis virus and herpes simplex virus move along different CNS pathways after intranasal inoculation. 1992 International Symposium on Coronaviruses.
Barnett EM, Perlman S. MHV-JHM and HSV-1: Neural pathways of infection in the mouse. American Society for Virology 1992 Annual Meeting.
Barnett EM
Barnett EM, Evans GD, Cassell MD, Perlman S. Anterograde transneuronal spread of herpes simplex virus from the murine tooth pulp to two cortical areas associated with jaw movement. Society for Neuroscience Abstracts 1993; 19:1210.
Evans GD, Barnett EM, Jacobsen GL, Cassell M, Perlman SM. Trigeminal herpes infection via murine pulp models human herpetic encephalitis. Journal of Dental Research 1994; 73:299.
Battiola RJ, Barnett EM. Who's fooling who? A survey of attending and resident physician attitudes regarding a ward medicine teaching service. Presented at Council of Transitional Year Program Directors 1996 AHM
Barnett EM, Luo X, Brasher A, Hicks D, Romano C. Culture and Immunocytochemical characterization of retinal neurons from adult human eyes. Association for Research in Vision and Ophthalmology 2002 Annual Meeting.
Camras CB, Sjoquist B, Toris CB, Thorngren J-O, Hassan F, Patel N, Hejkal TW, Hellman C, Milleson M, Barnett EM, Wax MB, Stjernschantz J. The hydrolysis of bimatoprost to its free acid in human eyes in vivo. American Academy of Ophthalmology 2003 Annual Meeting.
Camras CB, Sjoquist B, Toris CB, Thorngren J-O, Hassan F, Patel N, Hejkal TW, Hellman C, Milleson M, Barnett EM, Wax MB, Stjernschantz J. The hydrolysis of bimatoprost to its free acid in human eyes in vivo. American Glaucoma Society 2004 Annual Meeting.
Barnett EM, Bullok KE, Elangovan B, Romano C, Piwnica-Worms DR. Cellular uptake of modified HIV-1 Tat permeation peptide constructs conjugated to alexa fluor-594 in the rodent posterior segment in an ex-vivo model. Association for Research in V
Barnett EM, Elangovan B, Bullok KE, Piwnica-Worms D. Selective uptake of modified HIV-1 Tat permeation peptides in the rat retina following intraocular injection. Molecular Imaging 2004; 3:289.
Barnett EM, Elangovan B, Bullok K, Piwnica-Worms D. Selective uptake of permeation peptides in rodent retina following intraocular injection: in vivo imaging and RGC axonal transport. Association for Research in Vision and Ophthalmol
Barnett EM, Elangovan B, Chang Q, Bullok K, Piwnica-Worms D. Visualization of effector caspase activity in rat models of retinal ganglion cell apoptosis using an activatable fluorescent permeation peptide. Mol Imaging 2006; 5:432-3.
Barnett EM, Chang Q, Zhang X, Elangovan B, Piwnica-Worms D. Visualization of effector caspase activity in rat models of retinal ganglion cell apoptosis using an activatable fluorescent permeation peptide. Association for Research in Vision an
Maxwell D J, Chang Q, Barnett EM, Piwnica-Worms D. Development of a second generation near-infrared fluorescent peptide for apoptosis imaging. Society for Molecular Imaging 2007 Annual Meeting.
Zhang X, Maxwell D, Piwnica-Worms D, Barnett EM. Validation of an effector-caspase specific activatable fluorescent peptide probe in rodent models of RGC degeneration. Association for Research in Vision and Ophthalmology 2008 Annual Mee
Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, Ocular Hypertension Treatment Study Group. Retinal vein occlusions in the Ocular Hypertension Treatment Study. Association for Research in Vision and Ophthalmology 2008 Annual Meeting.
Barnett EM, Zhang X, Chang Q, Maxwell D, Johson J, Piwnica-Worms D. A second generation activatable cell-penetrating peptide probe for imaging effector caspase activity in an in vivo model of RGC degeneration. Association for Research in Vision and Ophthalmology 2009 Annual Meeting. Chang ST, Xu J, Trinkaus KM, Song S-K, Barnett EM. 3-T Diffusion Tensor Imaging of Optic Nerve Changes in Glaucoma. Association for Research in Vision and Ophthalmology 2010 Annual Meeting.
Johnson JR, Kocher B, Chang Q, Barnett EM, Piwnica-Worms D. Caspase-activated cell-penetrating probes for in vivo optical imaging of retinal neurodegeneration. 2010 In Vitro Biology Meeting.
Barnett EM, Qiu X, Johnson JR, Piwnica-Worms D. In vivo imaging of RGC uptake of activatable cell-penetrating probes for imaging apoptosis. American Glaucoma Society 2011 Meeting.
Qiu X, Johnson JR, Piwnica-Worms D, Barnett EM. In vivo confocal scanning laser ophthalmoscopy imaging of retinal ganglion cell apoptosis using caspase-activatable probes in a rat glaucoma model. Association for Research in Vision and
 
International
Jacobsen GL, Perlman SM, Evans GD, Barnett EM, Walton RE. Herpes spread from pulp to CNS via inferior alveolar nerve. 1992 General Session and Exhibition of the International Association for Dental Research.
Jacobsen GL, Perlman SM, Evans GD, Barnett EM, Walton RE. Herpes spread from pulp to CNS via inferior alveolar nerve. 1992 General Session and Exhibition of the International Association for Dental Research.
Jacobsen G, Barnett EM, Evans G, Walton R, Perlman S. Herpes spread from pulp into CNS extensions of trigeminal nerve. 1993 International & American Associations for Dental Research General Session and Exhibition.
Johnson JR, Kocher B, Maxwell DJ, Chang Q, Barnett EM, Piwnica-Worms D. Caspasase-activated cell-penetrating probes for in vivo optical imaging of retinal neurodegeneration. 2009 World Molecular Imaging Congress.
Barnett EM, Perlman, S. Mouse hepatitis virus and herpes simplex virus move along different CNS pathways after intranasal inoculation. 1992 International Symposium on Coronaviruses.
 

COMMITTEE SERVICE:
Medical College of Wisconsin
09/06/2015 - 06/01/2018 Departmental Representative, Faculty Council, Ophthalmology, Medical College of Wisconsin
07/01/2016 - Present Resident Steering Committee, Ophthalmology and Visual Science
Resident Interview/Selection Committee. Department of Ophthalmology & Visual Sciences. Washington University School of Medicine. St. Louis, Missouri. 2005-2012.
Translational Research Strategy & Oversight Committee. Eye Institute. Department of Ophthalmology. Medical College of Wisconsin. Milwaukee, Wisconsin. 2015
Meaningful Use Committee. Washington University School of Medicine. St. Louis, Missouri. 2010-2013.
Promotions Committee. Department of Ophthalmology & Visual Sciences. Washington University School of Medicine. St. Louis, Missouri. 2009.
 
Hospital
Kaleidoscope Steering Committee, Ophthalmology and Visual Sciences, Froedtert
Medical Staff Performance Committee. Barnes Jewish Hospital. St. Louis, Missouri. 2008-2013.
 

EXTRAMURAL TEACHING:
Medical Student Education
2000 - 2001 University of PIttsburgh School of Medicine, Facilitator, Integrated Case Studies Course
 
Graduate Student Education
2007 - 2011 Washington University in St. Louis, Lecturer, The Biology and Pathology of the Visual System (BIO5501)
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Washington University in St. Louis, School of Medicine, 2002 - 2005 MSTP Clinical Mentoring Program
Washington University in St. Louis School of Medicine, 2009 Mentor, Medical Student OPhthalmology Interest Group
 
Clinical/Research Fellows
Regina Smolyak, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2001 - 2002 Glaucoma Fellowship
Farid Hasan, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2002 - 2003
Lydia Dworkin, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2003 - 2004 Glaucoma Fellowship
Michael Levitt, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2004 - 2005 Glaucoma Fellowship
Prajay Dhir, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2005 - 2006 Glaucoma Fellowship
Thad Labbe, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2006 - 2007 Glaucoma Fellowship
Melike Pekmezci, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2007 - 2008 Research Fellowship
Shayna Mangers, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2007 - 2008 Glaucoma Fellowship
Suzanne Falkenberry, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2007 - 2008 Glaucoma Fellowship
Sidney Chang, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2008 - 2009 Research Fellowship
Sidney Chang, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2009 - 2010 Glaucoma Fellowship
Moya Brooks, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2011 - 2012 Glaucoma Fellowship
Nancy Buchser, M.D., Washington University in St. Louis Department of Ophthalmology and Visual Sciences, 2012 - 2013 Glaucoma Fellowship
Alan Lowinger, M.D., Ophthalmic Consultants of Boston/New England Eye Center, 2013 - 2014 Glaucoma Fellowship
Shlomit Sandler, M.D., Ophthalmic Consultants of Boston/New England Eye Center, 2013 - 2014 Glaucoma Fellowship
Claudia Bartolini, M.D., Ophthalmic Consultants of Boston/New England Eye Center, 2014 - 2015 Glaucoma Fellowship
Avneet Sodhi, M.D., Ophthalmic Consultants of Boston/New England Eye Center, 2014 - 2015 Glaucoma Fellowship
 

COURSE DIRECTOR:
04/14/2012 - Present Innovations in Glaucoma Surgery St. Louis, MO
08/24/2013 - Present Innovations in Glaucoma Surgery St. Louis, MO
04/09/2016 - Present Innovations in Glaucoma Surgery St. Louis, MO

MEETING ORGANIZER:
10/01/2016 - Present Medical College of Wisconsin Eye Institute 40th Anniversary Scientific Symposium

PLANNING GROUP:
2018 - 2020 American Academy of Ophthalmology Glaucoma Subspecialty Day Program

PROGRAM DIRECTOR:
09/28/2018 - 09/29/2018 41st Annual Midwest Glaucoma Symposium, Medical College of Wisconsin Eye Institute Annual Symposium


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Miller MB, Chapman LJ, Chapman JP, Barnett EM. Schizophrenic deficit in span of apprehension. J Abnorm Psychol. 1990 Aug;99(3):313-6.
2. Perlman S, Barnett E, Jacobsen G. Mouse hepatitis virus and herpes simplex virus move along different CNS pathways. Adv Exp Med Biol. 1993;342:313-8.
3. Barnett EM, Cassell MD, Perlman S. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience. 1993 Dec;57(4):1007-25. PMCID: PMC7131965
4. Barnett EM, Perlman S. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology. 1993 May;194(1):185-91.
5. Barnett EM, Jacobsen G, Evans G, Cassell M, Perlman S. Herpes simplex encephalitis in the temporal cortex and limbic system after trigeminal nerve inoculation. J Infect Dis. 1994 Apr;169(4):782-6.
6. Barnett EM, Evans GD, Sun N, Perlman S, Cassell MD. Anterograde tracing of trigeminal afferent pathways from the murine tooth pulp to cortex using herpes simplex virus type 1. J Neurosci. 1995 Apr;15(4):2972-84. PMCID: PMC6577775
7. Perlman S, Sun N, Barnett EM. Spread of MHV-JHM from nasal cavity to white matter of spinal cord. Transneuronal movement and involvement of astrocytes. Adv Exp Med Biol. 1995;380:73-8.
8. Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity. 1996 Sep;5(3):253-62.
9. Keltner JL, et al., for the Ocular Hypertension Treatment Study Group. Confirmation of visual vield abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol 2000; 118: 1187-1194
10. Piltz J, et al., and the Ocular Hypertension Treatment Study Group. Contralateral effect of topical b-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study. Am J Ophthalmol 2000; 130: 441-453.
11. Kass MA, et al., for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120:701-713.
12. Gordon MO, et al., for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120:714-720.
13. Keltner JL, et al., for the Ocular Hypertension Treatment Study Group. Classification of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol 2003; 121:643-650.
14. Camras CB, Toris CB, Sjoquist B, Milleson M, Thorngren JO, Hejkal TW, Patel N, Barnett EM, Smolyak R, Hasan SF, Hellman C, Meza JL, Wax MB, Stjernschantz J. Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery. Ophthalmology. 2004 Dec;111(12):2193-8.
15. Coleman AL, et al., for the Ocular Hypertension Treatment Study Group. Baseline risk factors for the development of POAG in the Ocular Hypertension Treatment Study. Am J Ophthalmol 2004; 138:684-685.
16. Brandt JD, et al., for the Ocular Hypertension Treatment Study Group. Central corneal thickness and measured IOP response to topical ocular hypotensive medication. Am J Ophthalmol 2004; 138:717-722.
17. Higginbotham EJ, et al., for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African-American individuals. Arch Ophthalmol 2004; 122:813-820.
18. Keltner JL, et al., for the Ocular Hypertension Treatment Study Group (OHTS). Normal visual field test results following glaucomatous visual field endpoints in the Ocular Hypertension Treatment Study. Arch Ophthalmol 2005; 123:1201-1206.
19. Parrish RK, et al., and the Ocular Hypertension Treatment Group: Test-retest Reproducibility of Optic Disk Deterioration Detected From Stereophotographs by Masked Graders. Am J Ophthalmol 2005; 140:762-764.
20. Barnett EM, Elangovan B, Bullok KE, Piwnica-Worms D. Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2589-95.
21. Keltner JL, et al., and the Ocular Hypertension Treatment Study Group. The Association between Glaucomatous Visual Fields and Optic Nerve Head Features in the OHTS. Ophthalmol 2006;113(9):1603-12.
22. Keltner JL, et al., for the Ocular Hypertension Treatment Study Group. The association between glaucomatous visuial fields and optic nerve head features in the Ocular Hypertension Treatment Study. Opthalmol 2006; 113:1603-1623.
23. Levine RA, Demirel S, Fan J, Keltner JL, Johnson CA, Kass MA, Ocular Hypertension Treatment Study Group. Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3896-903. PMCID: PMC1995656
24. Budenz DL et al. and the Ocular Hypertension Treatment Study (OHTS) Group. Detection and Prognostic Significance of Optic Disc Hemorrhages During the Ocular Hypertension Treatment Study. Ophthalmology 2006; 113(12):2137-43.
25. Kymes SM, et al., and the Ocular Hypertension Treatment Study (OHTS) Group. Management of ocular hypertension: A cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 2006;141:997-1008.
26. Levine RA, et al., and the Ocular Hypertension Treatment Study (OHTS) Group. Asymmetries and visual field summaries as predictors of glaucoma in the Ocular Hypertension Treatment Study (OHTS). Invest Ophthalmol Vis Sci 2006;47:3896-3903.
27. The Ocular Hypertension Treatment Study (OHTS) Group and the European Glaucoma Prevention Study (EGPS) Group. Validated Prediction Model for the Development of Primary Open-Angle Glaucoma in Individuals with Ocular Hypertension. Ophthalmology 2007; 114(1):10-9.
28. Keltner JL et al. and the Ocular Hypertension Treatment Study (OHTS) Group. Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS). J Glaucoma 2007; 16:665-9.
29. Nolan MJ, Giovingo MC, Miller AM, Wertz RD, Ritch R, Liebmann JM, Allingham RR, Herndon LW, Wax MB, Smolyak R, Hasan F, Barnett EM, Samples JR, Knepper PA. Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma. J Glaucoma. 2007 Aug;16(5):419-29.
30. Mansberger SL et al. and the Ocular Hypertension Treatment Study (OHTS) Group. Comparison of Initial Intraocular Pressure Response to Topical Beta-Adrenergic Antagonists and Prostaglandin Analogues in African Americans and Whites in the Ocular Hypertension Treatment Study (OHTS). Archives of Ophthalmology 2007; 125(4):454-9.
31. Gordon MO, Beiser JA, Kass MA for the Ocular Hypertension Treatment Study Group. Is a History of Diabetes Mellitus Protective Against Developing Primary Open-Angle Glaucoma? Arch Ophthalmol 2008; 126:280-2.
32. Kass MA, Gordon MO, for the Ocular Hypertension Treatment Study Group. Diabetes and Glaucoma. Arch Ophthalmol 2008;126(5):746-7.
33. Brandt JD, et al. and the Ocular Hypertension Treatment Study Group. Changes in Central Corneal Thickness Over Time: The Ocular Hypertension Treatment Study. Ophthalmology 2008; 115:1550-6.
34. The Ocular Hypertension Treatment Group and the European Glaucoma Prevention Study Group. The Accuracy and Clinical Application of Predictive Models for Primary Open-Angle Glaucoma in Ocular Hypertensive Individuals. Ophthalmology 2008; 115(11):2030-6.
35. Minckler D, et al., Trabectome Study Group. Trabectome (trabeculectomy-internal approach): additional experience and extended follow-up. Trans Am Ophthalmol Soc. 2008;106:149-59.
36. Francis BA, et al., Trabectome Study Group. Combined cataract extraction and trabeculotomy by the internal approach for coexisting cataract and open-angle glaucoma: initial results. J Cataract Refract Surg. 2008;34(7):1096-103.
37. Maxwell D, Chang Q, Zhang X, Barnett EM, Piwnica-Worms D. An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem. 2009 Apr;20(4):702-9. PMCID: PMC2672423
38. Bhorade AM, et al. and the Ocular Hypertension Treatment Study Group. Variability of Intraocular Pressure Measurements in Observation Participants in the Ocular Hypertension Treatment Study. Ophthalmology 2009; 116:717-24.
39. Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D. Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A. 2009 Jun 09;106(23):9391-6. PMCID: PMC2695102
40. Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, Ocular Hypertension Treatment Study Group. The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology. 2010 Mar;117(3):484-8. PMCID: PMC3077045
41. Vold SD, Dustin L; Trabectome Study Group. Impact of laser trabeculoplasty on Trabectome outcomes. Ophthalmic Surg Lasers Imaging. 2010;41(4):443-51.
42. Artes PH, et al. and the Ocular Hypertension Study Treatment Group. Longitudinal and Cross-Sectional Analyses of Visual Field Progression in Participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol 2010;128(12):1528-32.
43. Kass MA, et al. and the Ocular Hypertension Treatment Study (OHTS) Group. Delaying Treatment of Ocular Hypertension. Arch Ophthalmol 2010; 128(3):276-87.
44. Fujikawa K, Iwata T, Inoue K, Akahori M, Kadotani H, Fukaya M, Watanabe M, Chang Q, Barnett EM, Swat W. VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One. 2010 Feb 04;5(2):e9050. PMCID: PMC2816215
45. Gao F, et al. and the Ocular Hypertension Treatment Study (OHTS) Group. A joint-Modeling Approach to Assess the Impact of Biomarker Variability on the Risk of Developing Clinical Outcome. Statistical Methods & Applications 2011;20(1):83-100.
46. Johnson JR, Kocher B, Barnett EM, Marasa J, Piwnica-Worms D. Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model. Bioconjug Chem. 2012 Sep 19;23(9):1783-93. PMCID: PMC3447108
47. Ting JL, Damji KF, Stiles MC; Trabectome Study Group. Ab interno trabeulectomy: Outcomes in exfoliation versus primary open-angle glaucoma. J Cataract Refract Surg 2012;38(2):315-323
48. Gardiner SK, et al., Ocular Hypertension Treatment Study Group. Series length used during trend analysis affects sensitivity to changes in progression rate in the Ocular Hypertension Treatment Study. Invest Ophthalmol Vis Sci 2013; 54:1252-9.
49. Chang ST, Xu J, Trinkaus K, Pekmezci M, Arthur SN, Song SK, Barnett EM. Optic nerve diffusion tensor imaging parameters and their correlation with optic disc topography and disease severity in adult glaucoma patients and controls. J Glaucoma. 2014;23(8):513-20. PMCID: PMC3800509
50. Qiu X, Johnson JR, Wilson BS, Gammon ST, Piwnica-Worms D, Barnett EM. Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe. PLoS One. 2014;9(2):e88855. PMCID: PMC3931650
51. Qiu X, Gammon ST, Johnson JR, Pisaneschi F, Millward SW, Barnett EM, Piwnica-Worms D. Apoptosis Detection in Retinal Ganglion Cells Using Quantitative Changes in Multichannel Fluorescence Colocalization. Biosensors. 2022 Aug:12(9):693. PMCID: PMC9496076
 
Books, Chapters, and Reviews
1. Barnett EM The Eye Exam: A Complete Guide. Am J Ophthalmol 2006; 142:206
2. Barnett EM Gonioscopy: A Text and Atlas. Am J Ophthalmol 2007; 143: 912.
 
Editorials, Letters to Editor, Other
1. Kass MA, Gordon MO, Kymes SM for the Ocular Hypertension Treatment Study (OHTS) Group. Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice. Letter to Editor. Arch Ophthalmol 2005; 123:1021-1022.
 
Non-Refereed Journal Publications/Original Papers
1. Barnett, EM Prostaglandin Analogues: Development and Comparison. New Guidance for Glaucoma Control. Ocular Surgery News 2003; June: S6-8.
2. Barnett, EM Prostaglandin Analogues: Development and Comparison. New Guidance for Glaucoma Control. Ocular Surgery News 2003; June: S6-8.
3. Barnett, EM Novel Medical Therapeutic Approaches for Glaucoma. New Consideration in the Management of Ocular Hypertension and Glaucoma. Ocular Surgery News 2005; June: S8-10.